AIF1 and glioma: Using double immunostaining for Iba1 and Arg1 (a pro-tumorigenic phenotype marker) we demonstrated that a majority of GAMs accumulating in glioma-bearing hemispheres express Arg1, which suggests their pro-tumorigenic, immunosuppressive activation (Fig. 1C).